ORION CORPORATION STOCK EXCHANGE RELEASE 20 JANUARY 2012 at 8.00 AM EET
Orion will publish its Financial Statement Release for 2011 on Tuesday, 7 February 2012 approximately at 12:00 Finnish time (EET). The release and related presentation material in Finnish and in English will be available on the Group's homepage at promptly after the publishing.
News conference for analysts and media on Tuesday 7 February 2012 at 13:30 EETA news conference for analysts and media will be held on Tuesday 7 February 2012 at 13:30 EET atHotel Kämp, address Pohjoisesplanadi 29, Helsinki. President and CEO Timo Lappalainen will give a brief presentation in English on the financial review.
Live webcast and conference callThe event can be followed live as a webcast accessible at . Questions can be asked also through conference call lines after the result presentation.
The conference call ID is 910,481 and the phone numbers to
participate the conference are:
when calling from the United States +1 866 803 8344
when calling from other countries +44 (0)20 7162 0125
A recording of the event in English will be available later the same day via a link on the Orion website. A recording of the presentation by the President and CEO in Finnish will be available on the Orion website later the same day.
Silent periodThe silent period preceding the publication is ongoing and continues until the disclosure.
Orion Corporation
Timo Lappalainen President and CEO |
Jari Karlson CFO |
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi
Orion is an innovative European R&D-based pharmaceutical
and diagnostic company with a special emphasis on
developing medicinal treatments and diagnostic tests for
global markets. Orion develops, manufactures and markets
human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. Orion's
pharmaceutical R&D focuses on the following core therapy
areas: central nervous system drugs, cancer and critical
care drugs, and Easyhaler® pulmonary drugs.
The Group's net sales in 2010 amounted to EUR 850
million. The Company invested EUR 85 million in research
and development. At the end of 2010, the Group had a total
of approximately 3,100 employees, of whom 2,450 worked in
Finland and 650 in other countries. Orion's A and B
shares are listed on NASDAQ OMX Helsinki.
distribué par | Ce noodl a été diffusé par Orion Oyj et initialement mise en ligne sur le site http://www.orion.fi. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-20 07:55:32 AM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |